Wisconsin Western Bankruptcy Court

Case number: 3:17-bk-10315 - Enzyme Formulations, Inc. - Wisconsin Western Bankruptcy Court

Case Information
Case title
Enzyme Formulations, Inc.
Chapter
11
Judge
Catherine J. Furay
Filed
02/03/2017
Last Filing
09/28/2017
Asset
Yes
Vol
v
Docket Header

PLNDUE, DSCLSDUE, LEAD




U.S. Bankruptcy Court
Western District of Wisconsin, http://www.wiwb.uscourts.gov (Madison)
Bankruptcy Petition #: 3-17-10315-cjf

341 Hearing Location: Madison
Assigned to: Chief Judge Catherine J. Furay
Chapter 11
Voluntary
Asset

Associated Case(s):


Date filed:  02/03/2017
341 meeting (341mtg):  03/09/2017

Debtor

Enzyme Formulations, Inc.

6421 Enterprise Lane
Madison, WI 53719
DANE-WI
608-273-8100
Tax ID / EIN: 39-1809388

represented by
Matthew D. Lee

150 E. Gilman Street
P.O. Box 1497
Madison, WI 53703
608/258-4203
Email: [email protected]

U.S. Trustee

U.S. Trustee's Office

U.S. Trustee's Office
Suite 304
780 Regent Street
Madison, WI 53715
 
 

Latest Dockets
Date Filed#Docket Text
03/03/201783Docket Text
List of 20 Largest Unsecured Creditors filed by Matthew D. Lee on behalf of Enzyme Formulations, Inc.. (Lee, Matthew) (Entered: 03/03/2017)
03/03/201782Docket Text
Declaration filed by Matthew D. Lee on behalf of Enzyme Formulations, Inc.. Related document(s) 81 Schedules and Statements filed by Debtor Enzyme Formulations, Inc.. (Lee, Matthew) (Entered: 03/03/2017)
03/03/201781Docket Text
Summary of Assets and Liabilities, Schedule A/B, Schedule D, Schedule E/F, Schedule G, Schedule H, Statement of Financial Affairs, filed by Matthew D. Lee on behalf of Enzyme Formulations, Inc.. (Lee, Matthew) (Entered: 03/03/2017)
03/03/201780Docket Text
Notice of Appearance and Request for Notice and Consent to E-Service for Attorney Megan R. Stelljes filed by Matthew D. Lee on behalf of Enzyme Formulations, Inc.. (Lee, Matthew) (Entered: 03/03/2017)
03/02/201779Docket Text
Final Order (a) PROHIBITING UTILITY COMPANIES FROM ALTERING, REFUSING, OR DISCONTINUING SERVICES TO THE DEBTORS; (b) DEEMING UTILITY COMPANIES ADEQUATELY ASSURED OF FUTURE PERFORMANCE; AND (c) ESTABLISHING PROCEDURES TO DETERMINE REQUESTS FOR ADDITIONAL ADEQUATE ASSURANCE OF PAYMENTS cc: parties in int. (Related Doc # 5) Signed on 3/2/2017. (Madison, Tina) (Entered: 03/03/2017)
03/02/201778Docket Text
Periodic Report Regarding Value, Operations and Profitability of Entities in Which the Estate of Howard F. Loomis, Jr. Holds a Substantial or Controlling Interest filed by Matthew D. Lee on behalf of Enzyme Formulations, Inc.. (Lee, Matthew) (Entered: 03/02/2017)
02/28/201777Docket Text
PM/Final Hearing Held on Chapter 11 First Day Motion FOR INTERIM AND FINAL ORDERS (a) PROHIBITING UTILITY PROVIDERS FROM ALTERING, REFUSING, OR DISCONTINUING SERVICES TO THE DEBTORS; (b) DEEMING UTILITY PROVIDERS ADEQUATELY ASSURED OF FUTURE PERFORMANCE; AND (c) ESTABLISHING PROCEDURES TO DETERMINE REQUESTS FOR ADDITIONAL ADEQUATE ASSURANCE. OUTCOME: Granted; proposed order previously submitted to be signed (related document(s): 5 (tm ) (Entered: 02/28/2017)
02/21/201776Docket Text
Attorney Fee Disclosure, filed by Matthew D. Lee on behalf of Enzyme Formulations, Inc.. (Lee, Matthew) (Entered: 02/21/2017)
02/17/201775Docket Text
Proof of Service filed by Matthew D. Lee on behalf of Enzyme Formulations, Inc.. Related document(s) 72, 73, 74 Motion to Set Last Day to File Proofs of Claim filed by Debtor Enzyme Formulations, Inc., Notice of Motion filed by Debtor Enzyme Formulations, Inc., Proposed Order filed by Debtor Enzyme Formulations, Inc.. (Lee, Matthew) (Entered: 02/17/2017)
02/16/201774Docket Text
Proposed Order (related document(s) 72 Motion to Set Last Day to File Proofs of Claim filed by Debtor Enzyme Formulations, Inc.) filed by Attorney Matthew D. Lee on behalf of Enzyme Formulations, Inc. . Order to be signed on or after 3/2/2017. (Lee, Matthew) (Entered: 02/16/2017)